Form 4: Sera Prognostics CSO Sells Shares for Tax Obligations

Sera Prognostics' Chief Scientific Officer, John J. Boniface, sold 1,395 shares of Class A Common Stock to cover tax withholding obligations related to RSU vesting.

Summary

• John J. Boniface, Chief Scientific Officer of Sera Prognostics, Inc. (SERA), sold 1,395 shares of Class A Common Stock.
• The transaction occurred on September 11, 2025, at a weighted average price of $3.13 per share, with individual sales ranging from $3.05 to $3.24.
• The sale was non-discretionary and mandated by the issuer to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following the transaction, Mr. Boniface beneficially owns 159,493 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary 'sell to cover' to meet tax obligations upon RSU vesting, which is a neutral event for the company's operational or strategic outlook.

Positives

• The sale was non-discretionary, indicating it was not a voluntary decision by the officer to reduce their stake due to a negative outlook on the company.
• The transaction is a standard and expected procedure for covering tax liabilities upon RSU vesting.

Negatives

• A reduction in direct beneficial ownership, even if non-discretionary, slightly decreases the officer's direct equity stake.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Management Comments

• Management clarified that the sale was a mandatory 'sell to cover' transaction to satisfy tax withholding obligations, not a discretionary sale by the reporting person.

Industry Context

This routine insider transaction does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is non-discretionary and for tax purposes, not indicative of a change in management's confidence.
• Employees: The transaction highlights the standard process for equity compensation and tax obligations for executives.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary 'sell to cover' transaction by a Chief Scientific Officer to satisfy tax obligations related to RSU vesting. Such transactions are common and do not reflect a change in the officer's confidence in the company's future prospects or its operational performance. Therefore, it provides no new information that would warrant a change in investment recommendation; a 'hold' stance is appropriate as this filing does not present a material positive or negative catalyst.

Keywords

Sera Prognostics, SERA, Form 4, Insider Trading, Stock Sale, Chief Scientific Officer, John J. Boniface, Restricted Stock Units, RSU Vesting, Tax Withholding